Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Neurobiol Dis ; 65: 82-92, 2014 May.
Article in English | MEDLINE | ID: mdl-24412310

ABSTRACT

The spreading of pathology through neuronal pathways is likely to be the cause of the progressive cognitive loss observed in Alzheimer's disease (AD) and other neurodegenerative diseases. We have recently shown the propagation of AD pathology via cell-to-cell transfer of oligomeric amyloid beta (Aß) residues 1-42 (oAß1-42) using our donor-acceptor 3-D co-culture model. We now show that different Aß-isoforms (fluorescently labeled 1-42, 3(pE)-40, 1-40 and 11-42 oligomers) can transfer from one cell to another. Thus, transfer is not restricted to a specific Aß-isoform. Although different Aß isoforms can transfer, differences in the capacity to clear and/or degrade these aggregated isoforms result in vast differences in the net amounts ending up in the receiving cells and the net remaining Aß can cause seeding and pathology in the receiving cells. This insufficient clearance and/or degradation by cells creates sizable intracellular accumulations of the aggregation-prone Aß1-42 isoform, which further promotes cell-to-cell transfer; thus, oAß1-42 is a potentially toxic isoform. Furthermore, cell-to-cell transfer is shown to be an early event that is seemingly independent of later appearances of cellular toxicity. This phenomenon could explain how seeds for the AD pathology could pass on to new brain areas and gradually induce AD pathology, even before the first cell starts to deteriorate, and how cell-to-cell transfer can act together with the factors that influence cellular clearance and/or degradation in the development of AD.


Subject(s)
Amyloid beta-Peptides/metabolism , Cell Communication/physiology , Neurites/metabolism , Peptide Fragments/metabolism , Amyloid beta-Peptides/ultrastructure , Brain-Derived Neurotrophic Factor/pharmacology , Cell Differentiation/drug effects , Cell Line, Transformed , Coculture Techniques , Extracellular Matrix/physiology , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Humans , Lysosomes/metabolism , Lysosomes/ultrastructure , Membrane Potential, Mitochondrial/drug effects , Nerve Growth Factor/pharmacology , Neuregulin-1/pharmacology , Neurites/ultrastructure , Neuroblastoma/pathology , Peptide Fragments/ultrastructure , Protein Isoforms , Time Factors , Tretinoin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...